APTX Stock Analysis

APTX -  USA Stock  

USD 3.10  0.15  4.62%

The modest gains experienced by current holders of Aptinyx could raise concerns from investors as the firm it trading at a share price of 3.10 on 930,800 in volume. The company management teams have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in May. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.44. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Aptinyx partners.
Please continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Aptinyx stock analysis report makes it easy to digest most publicly released information about Aptinyx and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. APTX stock analysis module also helps to analyze the Aptinyx price relationship with some important fundamental indicators such as market cap and management efficiency.

APTX Stock Analysis Notes

About 67.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aptinyx recorded a loss per share of 1.02. The entity had not issued any dividends in recent years. Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people. For more info on Aptinyx please contact Norbert Riedel at 847 871 0377 or go to http://www.aptinyx.com.

Aptinyx Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aptinyx's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aptinyx or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aptinyx has very high historical volatility over the last 90 days
Aptinyx has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 1.56 M. Net Loss for the year was (50.05 M) with loss before overhead, payroll, taxes, and interest of (31.27 M).
Aptinyx currently holds about 141.03 M in cash with (42.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.11.
Aptinyx has a frail financial position based on the latest SEC disclosures
Roughly 67.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.nasdaq.com: Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Wednesday - Nasdaq

Aptinyx Upcoming and Recent Events

Earnings reports are used by Aptinyx to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aptinyx previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report12th of August 2021
Next Earnings Report11th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End23rd of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

APTX Largest EPS Surprises

Earnings surprises can significantly impact Aptinyx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-05-14
2019-03-31-0.4526-0.5-0.047410 
2020-11-12
2020-09-30-0.2919-0.240.051917 
2021-03-24
2020-12-31-0.2377-0.170.067728 
View All Earnings Estimates

Aptinyx SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Aptinyx prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Aptinyx investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Aptinyx specific information freely available to individual and institutional investors to make a timely investment decision.
1st of June 2021
Submission of Matters to a Vote of Security Holders
View
13th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
10th of May 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
4th of May 2021
Unclassified Corporate Event
View
26th of March 2021
Unclassified Corporate Event
View
24th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
4th of February 2021
Unclassified Corporate Event
View
29th of January 2021
Unclassified Corporate Event
View

APTX Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aptinyx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aptinyx backward and forwards among themselves. Aptinyx's institutional investor refers to the entity that pools money to purchase Aptinyx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Bain Capital Life Sciences Investors LlcCommon Shares8.9 M26.7 M
Artal Group SaCommon Shares6.1 M18.3 M
Adams Street Partners LlcCommon Shares5.3 M15.9 M
New Leaf Venture Partners LlcCommon Shares3.3 M9.9 M
Frazier Management LlcCommon Shares3.2 M9.6 M
Blackrock IncCommon Shares3.1 M9.2 M
Vanguard Group IncCommon Shares1.7 M5.1 M
Note, although Aptinyx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

APTX Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 234.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aptinyx's market, we take the total number of its shares issued and multiply it by Aptinyx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

APTX Profitablity

Aptinyx's profitability indicators refer to fundamental financial ratios that showcase Aptinyx's ability to generate income relative to its revenue or operating costs. If, let's say, Aptinyx is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aptinyx's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aptinyx's profitability requires more research than a typical breakdown of Aptinyx's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.39) (0.42) 
Return on Average Equity(0.40) (0.41) 
Return on Invested Capital(14.55) (14.93) 
Return on Sales(32.00) (32.84) 

Management Efficiency

The entity has return on total asset (ROA) of (24.68) % which means that it has lost $24.68 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (40.49) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx management efficiency ratios could be used to measure how well aptinyx manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.42 in 2021. Return on Average Equity is likely to drop to -0.41 in 2021. Aptinyx Assets Non Current are fairly stable at the moment as compared to the past year. Aptinyx reported Assets Non Current of 1 Million in 2020. Asset Turnover is likely to rise to 0.0123 in 2021, whereas Total Assets are likely to drop slightly above 140.5 M in 2021.
Last ReportedProjected for 2021
Book Value per Share 2.99  3.22 
Enterprise Value over EBIT(2.30) (2.48) 
Enterprise Value over EBITDA(2.31) (2.50) 
Price to Book Value 1.50  1.68 
Tangible Assets Book Value per Share 3.08  4.70 
Enterprise Value114.9 M131.2 M
Tangible Asset Value150.6 M140.5 M

Technical Drivers

As of the 19th of June, Aptinyx shows the Downside Deviation of 5.11, risk adjusted performance of 0.0313, and Mean Deviation of 3.79. Aptinyx technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Aptinyx, which can be compared to its rivals. Please confirm Aptinyx variance and potential upside to decide if Aptinyx is priced correctly, providing market reflects its regular price of 3.1 per share. Given that Aptinyx has jensen alpha of 0.0205, we suggest you to validate Aptinyx's prevailing market performance to make sure the company can sustain itself at a future point.

Aptinyx Price Movement Analysis

The output start index for this execution was six with a total number of output elements of three hundred fourty-one. The Weighted Moving Average calculates a weight for each value in Aptinyx price series with the more recent values given greater weights. View also all equity analysis or get more info about weighted moving average overlap studies indicator.

Aptinyx Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aptinyx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aptinyx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aptinyx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Miller Joan W over two weeks ago via Macroaxis 
Acquisition by Miller Joan W of 40000 shares of Aptinyx subject to Rule 16b-3
Ashish Khanna over three weeks ago via Macroaxis 
Exercise or conversion by Ashish Khanna of 130000 shares of Aptinyx subject to Rule 16b-3
Miller Joan W over a month ago via Macroaxis 
Acquisition by Miller Joan W of 80000 shares of Aptinyx subject to Rule 16b-3
Ashish Khanna over three months ago via Macroaxis 
Acquisition by Ashish Khanna of 303400 shares of Aptinyx subject to Rule 16b-3
Henry Gosebruch over three months ago via Macroaxis 
Acquisition by Henry Gosebruch of 53 shares of Aptinyx subject to Rule 16b-3
Andrew Kidd over six months ago via Macroaxis 
Acquisition by Andrew Kidd of 415000 shares of Aptinyx subject to Rule 16b-3
Bain Capital Life Sciences Investors Llc over six months ago via Macroaxis 
Purchase by Bain Capital Life Sciences Investors Llc of 3333333 shares of Aptinyx
Henry Gosebruch over six months ago via Macroaxis 
Acquisition by Henry Gosebruch of 5490 shares of Aptinyx subject to Rule 16b-3
Adams Street Partners Llc over six months ago via Macroaxis 
Aptinyx exotic insider transaction detected
Henry Gosebruch over six months ago via Macroaxis 
Acquisition by Henry Gosebruch of 4051 shares of Aptinyx subject to Rule 16b-3
Sherman Rachel E over a year ago via Macroaxis 
Acquisition by Sherman Rachel E of 40000 shares of Aptinyx subject to Rule 16b-3
Norbert Riedel over a year ago via Macroaxis 
Aptinyx exotic insider transaction detected

Aptinyx Predictive Daily Indicators

Aptinyx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aptinyx stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aptinyx Forecast Models

Aptinyx time-series forecasting models is one of many Aptinyx's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aptinyx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Aptinyx Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aptinyx stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling APTX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Aptinyx. By using and applying APTX Stock analysis, traders can create a robust methodology for identifying APTX entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(31.73) (32.57) 
Gross Margin 0.90  0.89 
Profit Margin(32.00) (32.84) 
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Current APTX Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. APTX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. APTX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
9.71Buy7Odds
Aptinyx current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most APTX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand APTX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aptinyx, talking to its executives and customers, or listening to APTX conference calls.
APTX Analyst Advice Details

APTX Stock Analysis Indicators

Aptinyx stock analysis indicators help investors evaluate how Aptinyx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aptinyx shares will generate the highest return on investment. By understating and applying Aptinyx stock analysis, traders can identify Aptinyx position entry and exit signals to maximize returns.
Quick Ratio30.83
Fifty Two Week Low2.3000
Revenue Growth-100.00%
Shares Short Prior Month1.99M
Average Daily Volume Last 10 Day5.69M
Average Daily Volume In Three Month937.62k
Shares Percent Shares Out3.37%
Short Percent Of Float4.25%
Forward Price Earnings-3.57
Float Shares41.58M
Fifty Two Week High6.4700
Enterprise Value To Ebitda-0.76
Fifty Day Average2.6641
Two Hundred Day Average3.2832
Enterprise Value To Revenue24.45
Please continue to Trending Equities. Note that the Aptinyx information on this page should be used as a complementary analysis to other Aptinyx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Aptinyx Stock analysis

When running Aptinyx price analysis, check to measure Aptinyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptinyx is operating at the current time. Most of Aptinyx's value examination focuses on studying past and present price action to predict the probability of Aptinyx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aptinyx's price. Additionally, you may evaluate how the addition of Aptinyx to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
The market value of Aptinyx is measured differently than its book value, which is the value of APTX that is recorded on the company's balance sheet. Investors also form their own opinion of Aptinyx's value that differs from its market value or its book value, called intrinsic value, which is Aptinyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptinyx's market value can be influenced by many factors that don't directly affect Aptinyx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptinyx's value and its price as these two are different measures arrived at by different means. Investors typically determine Aptinyx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptinyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.